Protalix BioTherapeutics PLX
NYSE PLX
$2.56 -0.01 (-0.58%)
As of: Oct 22, 2026 · 2:19 PM EDT

Protalix BioTherapeutics (PLX) Long-Term Debt Issuances (2013 - 2016)

Updated

Protalix BioTherapeutics (PLX) posted Long-Term Debt Issuances of $9.54 million for FY2017, down 51.5% from $19.68 million in FY2016.

Analysis

Protalix BioTherapeutics (PLX) Long-Term Debt Issuances (2013 - 2016) Analysis & Trends

  • Annual Long-Term Debt Issuances shows a four-year compound annual growth rate of -38.5% (FY2013 to FY2017).
  • Business Quant data shows PLX's Long-Term Debt Issuances at $19.68 million in FY2016 and $66.78 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn -
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn -
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn -
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn -
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn -
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Protalix BioTherapeutics 204.37 Mn 52.98 Mn 12.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 19.68 Mn
Dec 31, 2013 -150,000.00
API Access

Protalix BioTherapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PLX&period=max&api_key=YOUR_API_KEY